Joseph Yanchik news from FierceBiotech
News
Emerging Drug Developer: Aileron Therapeutics
Aileron Therapeutics ramps up, aims big When Joseph A. Yanchik III started Aileron Therapeutics back in the middle of 2005, Apple Tree Partners came in and provided the seed money. He started with Read more...
Aileron, Heritage Pharma each raise $10M in VC
Novartis Venture Funds and Apple Tree Partners have teamed up to lead a $10 million venture round for Cambridge, MA-based Aileron Therapeutics. Aileron says it will use much of the money to expand Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets